Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2012
05/30/2012CN101184726B 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
05/29/2012US8188276 2,4-pyrimidinediamine compounds and their uses
05/29/2012US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
05/29/2012US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
05/29/2012US8188249 Nucleic acid molecules encoding antibodies to M-CSF
05/29/2012US8188216 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents
05/29/2012US8188146 Highly purified ethyl EPA and other EPA derivatives
05/29/2012US8188113 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies
05/29/2012US8188107 T-614 is a cyclooxygenase-2 inhibitor; reduced plasma concentrations of an opioid analgesic, while still providing effective pain management; side effect reduction
05/29/2012US8188100 Adenosine derivatives as A2A receptor agonists
05/29/2012US8188084 Pyridinone and pyridazinone derivatives as inhibitors of poly (ADP-ribose) polymerase (PARP)
05/29/2012US8188074 Biologically active methylene blue derivatives
05/29/2012CA2687927C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
05/29/2012CA2582556C Formulations and methods for treating amyloidosis
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2554751C Anti-inflammatory analgesic for external use
05/29/2012CA2529561C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
05/29/2012CA2512487C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2495350C Use of lck inhibitor for treatment of immunologic diseases
05/29/2012CA2495260C Resolvins: biotemplates for novel therapeutic interventions
05/29/2012CA2482499C Aerosol containing a particulate active substance
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2442168C N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
05/29/2012CA2441597C Elongated and multiple spacers in activatible prodrugs
05/29/2012CA2417389C Therapeutic polyesters and polyamides
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/29/2012CA2377957C Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
05/29/2012CA2220777C Novel heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/24/2012WO2012068540A2 Neutralizing anti-ccl20 antibodies
05/24/2012WO2012068529A2 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
05/24/2012WO2012068454A2 Nrf2 deficiency influences susceptibility to steroid resistance via hdac2 reduction
05/24/2012WO2012068343A1 Quinoline derivatives as pik3 inhibitors
05/24/2012WO2012068209A2 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
05/24/2012WO2012068204A1 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012WO2012068196A1 Bis heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012WO2012067963A1 Nampt inhibitors
05/24/2012WO2012067822A1 Pyrazolo [1, 5 -a] pyrimidin potassium channel modulators
05/24/2012WO2012067491A2 Compositions comprising extracts obtained from oil palm based materials for providing anti -inflammatory effects and method of producing thereof
05/24/2012WO2012066994A1 Pharmaceutical formulation having neuroprotective activity
05/24/2012WO2012066896A1 Combined pharmaceutical preparation
05/24/2012WO2012065212A1 Anti-inflammatory compositions
05/24/2012WO2012037043A8 Treatment of autoimmune inflammation using mir-155
05/24/2012WO2012018499A3 Specific regulation of cytokine levels by hdac6 inhibitors
05/24/2012WO2012015704A3 Peripherally restricted faah inhibitors
05/24/2012WO2011163539A3 nAChRα7 AGONISTS AND nAChRα7 ANTAGONISTS FOR TREATING ULCERATIVE COLITIS (UC) AND CROHN'S DISEASE (CD)
05/24/2012WO2011152671A9 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin
05/24/2012WO2011047055A8 Novel mek inhibitors, useful in the treatment of diseases
05/24/2012US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics
05/24/2012US20120130199 Methods for Treating Chronic or Unresolvable Pain and/or Increasing the Pain Threshold in a Subject and Pharmaceutical Compositions for Use Therein
05/24/2012US20120129948 Medical implant producing wear particles with benign body response
05/24/2012US20120129935 Nutrition with lipids and non-digestible saccharides
05/24/2012US20120129932 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
05/24/2012US20120129930 Ketone compounds and compositions for cholesterol management and related uses
05/24/2012US20120129917 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
05/24/2012US20120129906 Modulators of s1p receptors
05/24/2012US20120129897 Bis heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129892 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
05/24/2012US20120129888 Libraries of n-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for drug discovery
05/24/2012US20120129886 Metalloenzyme inhibitor compounds
05/24/2012US20120129885 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof
05/24/2012US20120129873 Inhibitors of bruton's tyrosine kinase
05/24/2012US20120129872 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129870 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
05/24/2012US20120129868 Poly (adp-ribose) polymerase (parp) inhibitors
05/24/2012US20120129867 Inhibitors of protein kinases
05/24/2012US20120129866 Methods for preventing or treating metabolic diseases, inflammatory diseases, autoimmune diseases, allergic diseases, central nervous system diseases, cardiovascular diseases, homeostasis-related diseases or glaucoma
05/24/2012US20120129864 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same
05/24/2012US20120129863 Chymase inhibitors
05/24/2012US20120129862 Prokineticin 1 receptor antagonists
05/24/2012US20120129858 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
05/24/2012US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation
05/24/2012US20120129852 Azaindazoles as kinase inhibitors and use thereof
05/24/2012US20120129851 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
05/24/2012US20120129850 Imidazolothiazole compounds for the treatment of disease
05/24/2012US20120129849 Deuterated serine-threonine protein kinase modulators
05/24/2012US20120129845 Inhibitors of Bruton's Tyrosine Kinase
05/24/2012US20120129843 Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129842 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
05/24/2012US20120129829 Novel indole modulators of s1p receptors
05/24/2012US20120129820 New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
05/24/2012US20120129819 Gel compositions for administration of pharmaceutically active compounds
05/24/2012US20120129818 Compositions and Methods for Treatment of Cardiovascular Disease
05/24/2012US20120129814 Novel phosphonic acids as s1p receptor modulators
05/24/2012US20120129813 Novel compounds as receptor modulators with therapeutic utility
05/24/2012US20120129811 Tricyclic inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129789 Compositions and methods for hair growth
05/24/2012US20120129783 Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
05/24/2012US20120129782 Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders
05/24/2012US20120129779 Tubulysine derivatives
05/24/2012US20120129776 Bioactive peptides and method of using same
05/24/2012US20120128801 Combination herbal product to benefit respiratory tract in people exposed to smoke
05/24/2012US20120128793 Implantable or insertable medical device resistant to microbial growth and biofilm formation
05/24/2012US20120128787 Homeopathic Composition Comprising Hypericum Perforatum Extract And Essential Oils For The Treatment Of Neuropathic Pain
05/24/2012US20120128771 Timed, pulsatile release systems
05/24/2012US20120128768 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
05/24/2012US20120128763 Lubricant for the ocular surface
05/24/2012US20120128755 Personal Care Composition Containing Yeast Extract And Hexapeptide
05/24/2012US20120128753 Meditowel pre-packaged medicated muscle and joint pain relief wipe
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 1272